NCI Definition: A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that contain intracytoplasmic mucin and may resemble the epithelial cells of the endocervix or gastrointestinal tract. [1]

Ovarian mucinous tumors most frequently harbor alterations in KRAS, TP53, CDKN2A, CDKN2B, and PIK3CA [2].

Most Commonly Altered Genes in Ovarian Mucinous Tumor

KRAS Mutation, KRAS Exon 2 Mutation, KRAS Codon 12 Missense, TP53 Mutation, and TP53 c.217-c.1178 Missense are the most common alterations in ovarian mucinous tumor [2].

Top Alterations in Ovarian Mucinous Tumor

Disease Details

Mucinous Neoplasm of the Ovary, Mucinous Neoplasm of Ovary, Mucinous Tumor of Ovary, Ovarian Mucinous Neoplasm, Mucinous Tumor of the Ovary
Ovarian Epithelial Tumor
Ovarian Mucinous Adenofibroma, Malignant Ovarian Mucinous Tumor, Ovarian Mucinous Cystadenoma, and Borderline Ovarian Mucinous Tumor


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.